Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Protocols


EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.


Title Abstract Investigator
BRSCWRef Set Application: Michael Wilson - EIC Laboratories, Inc (2007) Samples were returned unused. Analysis never completed. Wilson, Michael S.
Barrett's Esophagus Methylation Profiles We propose a nested case-control study of biomarkers in the setting of BE. By bringing together research institutions with large populations of patients with ... Meltzer, Stephen
Basophile: Accurate Fragment Charge State Prediction Improves Peptide Identification Rates In shotgun proteomics, database search algorithms rely on fragmentation models to predict fragment ions that should be observed for a given peptide sequence. ... Wang, Dong
Benign Breast Disease Team Project To identify women diagnosed with atypical ductal hyperplasia (ADH) who are at increased risk of developing invasive breast cancer (IBC) and who might benefit ... Engstrom, Paul
Benign Breast Disease/DCIS Team Project To identify women diagnosed with atypical ductal hyperplasia (ADH) who are at increased risk of developing invasive breast cancer (IBC) and who might benefit ... Engstrom, Paul
Biomarker Detection Using NAPPA Tumor Antigen Arrays: EDRN Supplement The overall goal of this project application for the EDRN set-aside funds is to focus our collaborative efforts to identify p53 mutation-specific antibody ... Anderson, Karen
Biomarker Dev Lab At Moffitt Supplement Tockman, Melvyn S.
Biomarker Development Laboratory Zhao, Yingming
Biomarker Discovery for Renal Cell Carcinoma Through Serum, Urine and Tissue Protein Profiles Basler, Joseph W.
Biomarker Reference Sets for Cancers in Women The purpose of this study is to develop a standard reference set of specimens for use by investigators participating in the National Cancer Institutes Early ... Cramer, Daniel
Biomarkers and clinical parameters associated with Gleason score upgrading Thompson, Ian M.
Biomarkers for Prostate and Bladder Cancer CD26+ cancer cells and CD90+ tumor-associated stromal cells were sorted from tumor tissue. Dataset analysis with transcriptomes of CD26+ luminal, CD104+ basal, ... Liu, Alvin Y.
Biomarkers for early detection of pancreatic cancer Background: The clinical management of pancreatic cancer is severely hampered by the absence of effective screening tools. Methods: Sixty-seven biomarkers ... Lokshin, Anna
Biomarkers for the Early Detection of Pancreatic Cancer Killary, Ann M.
Biomarkers in Familial Multiple Myeloma Lynch, Henry
Biomarkers of Risk for Colorectal Neoplasia To explore biomarkers of risk of adenoma and adenoma recurrence Schoen, Robert E.
Biomarkers of Risk for Colorectal Neoplasia (Team Project #2) Investigators in the colon section of EDRN have a mutual interest in developing markers that would identify individuals at increased risk for colon neoplasia. ... Schoen, Robert E.
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non- progressing cancers We hypothesize that our novel Biomarker Panel of Auto-antibodies can distinguish aggressive, symptom diagnosed lung cancer from non-aggressive, screen-detected ... Rom, William
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non-progressing Cancer Distinguishing aggressive cancers from non-aggressive or non-progressing cancers is an issue of both clinical and public health importance particularly for ... Li, Christopher
Body Fluids as a Source of Diagnostic Biomarkers Semmes, John
Body Fluids as a Source of Diagnostic Biomarkers: Breast Semmes, John
Body Fluids as a Source of Diagnostic Biomarkers: Prostate Recent advances in high-throughput protein expression profiling of bodily fluids has generated great enthusiasm and hope for this approach as a potent ... Semmes, John
Breast Cancer: subgroups specific blood-biomarkers for early / predictive diagnosis and personalized treatment Breast-conserving lumpectomy followed by radiation therapy has been shown to be an alternative strategy, competitive to mastectomy, in preventing mortality ... Golubnitschaja, Prof. Dr. Olga
Breast Ductal Lavage Fluid Specimen Bank Trock, Bruce
Breast Ref Applicant: Abbott-Arkansas Medical Sciences (2013) We are evaluating whether detection of a tumor-specific N-linked glycosylation known as B 1,6 branched N-glycan present on the glycoprotein periostin in breast ... Abbott, Karen
Breast Ref Applicant: Anderson-Arizona (2014) The aims of the proposal are to evaluate this panel of 28 AAb biomarkers using the EDRN reference set. We propose to use RAPID ELISA containing each of these ... Anderson, Karen
Breast Ref Applicant: Chris Li (2014) Li, Christopher
Breast Ref Applicant: Chris Li-FHCRC (2014) Li, Christopher
Breast Ref Applicant: Mukherhjee-CanDiag (2014) Mukherhjee, Pinku
Breast Ref Applicant: Mukherjee 2014 Mukherhjee, Pinku
2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.